Bontempo Ohly Capital Mgmt LLC Boosts Stake in The Clorox Company (NYSE:CLX)

Bontempo Ohly Capital Mgmt LLC raised its holdings in shares of The Clorox Company (NYSE:CLX) by 0.6% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 28,382 shares of the company’s stock after purchasing an additional 163 shares during the quarter. Clorox accounts for about 1.9% of Bontempo Ohly Capital Mgmt LLC’s portfolio, making the stock its 16th largest position. Bontempo Ohly Capital Mgmt LLC’s holdings in Clorox were worth $3,873,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of CLX. Core Wealth Advisors Inc. purchased a new position in Clorox during the 4th quarter valued at $29,000. Innealta Capital LLC bought a new position in shares of Clorox in the second quarter worth about $30,000. Trifecta Capital Advisors LLC increased its stake in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the period. GoalVest Advisory LLC bought a new stake in Clorox during the 1st quarter valued at about $31,000. Finally, First Foundation Advisors purchased a new stake in Clorox in the 1st quarter valued at about $31,000. Institutional investors own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Citigroup raised their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Argus upgraded Clorox to a “hold” rating in a report on Tuesday, June 4th. Barclays raised their price target on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research note on Monday, August 5th. DA Davidson reaffirmed a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a research note on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Six equities research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $143.33.

Clorox Price Performance

Shares of CLX opened at $163.42 on Friday. The company has a 50 day moving average of $151.92 and a two-hundred day moving average of $144.05. The company has a market cap of $20.29 billion, a price-to-earnings ratio of 84.67, a price-to-earnings-growth ratio of 3.31 and a beta of 0.40. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.09.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The firm had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. As a group, analysts predict that The Clorox Company will post 6.63 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 2.99%. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.51% of the stock is owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.